Litigation Details for AltaThera Pharmaceuticals LLC v. Hyloris Pharmaceuticals SA (N.D. Ill. 2022)
✉ Email this page to a colleague
AltaThera Pharmaceuticals LLC v. Hyloris Pharmaceuticals SA (N.D. Ill. 2022)
| Docket | ⤷ Sign Up | Date Filed | 2022-08-30 |
| Court | District Court, N.D. Illinois | Date Terminated | 2023-09-15 |
| Cause | 18:1836(a) Injunction against Misappropriation of Trade Secrets | Assigned To | Jeremy C. Daniel |
| Jury Demand | Plaintiff | Referred To | |
| Parties | HYLORIS PHARMACEUTICALS SA | ||
| Patents | 10,512,620 | ||
| Attorneys | Philip L. Hirschhorn | ||
| Firms | Butler Weihmuller Katz Craig LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in AltaThera Pharmaceuticals LLC v. Hyloris Pharmaceuticals SA
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for AltaThera Pharmaceuticals LLC v. Hyloris Pharmaceuticals SA (N.D. Ill. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2022-08-30 | 1 | Complaint | published when the patent issued on December 24, 2019 as U.S. Patent No. 10,512,620. …use until December 24, 2019, when U.S. Patent No. 10,512,620 issued and was published. …December 24, 2019 when it issued as U.S. Patent No. 10,512,620. 148. Each of the first draft… earliest, December 24, 2019, when U.S. Patent No. 10,512,620 issued and was published. 166. …December 24, 2019 when it issued as U.S. Patent No. 10,512,620. 168. Each of the first draft | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
